|
1
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi
H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y,
Kinjo Y and Fukuda H: Surgery plus chemotherapy compared with
surgery alone for localized squamous cell carcinoma of the thoracic
esophagus: a Japan Clinical Oncology Group Study - JCOG9204. J Clin
Oncol. 21:4592–4596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adham M, Baulieux J, Mornex F, de La Roche
de Bransat E, Ducerf C, Souquet JC and Gerard JP: Combined
chemotherapy and radiotherapy followed by surgery in the treatment
of patients with squamous cell carcinoma of the esophagus. Cancer.
89:946–954. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y
and Kitajima M: Improvement in the results of surgical treatment of
advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg. 232:225–232. 2000.PubMed/NCBI
|
|
4
|
Morita M, Yoshida R, Ikeda K, Egashira A,
Oki E, Sadanaga N, Kakeji Y, Yamanaka T and Maehara Y: Advances in
esophageal cancer surgery in Japan: an analysis of 1000 consecutive
patients treated at a single institute. Surgery. 143:499–508. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho Y, Miyamoto M, Kato K, Fukunaga A,
Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki
M, Nakakubo Y, Hiraoka K, Murakami S, Shinohara T, Itoh T, Okushiba
S, Kondo S and Katoh H: CD4+ and CD8+ T cells
cooperate to improve prognosis of patients with esophageal squamous
cell carcinoma. Cancer Res. 63:1555–1559. 2003.
|
|
6
|
Kim R, Emi M and Tanabe K: Cancer
immunoediting from immune surveillance to immune escape.
Immunology. 121:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garrido F, Ruiz-Cabello F, Cabrera T,
Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M and Stern PL:
Implications for immunosurveillance of altered HLA class I
phenotypes in human tumours. Immunol Today. 18:89–95. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seliger B, Maeurer MJ and Ferrone S:
Antigen-processing machinery breakdown and tumor growth. Immunol
Today. 21:455–464. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seliger B, Cabrera T, Garrido F and
Ferrone S: HLA class I antigen abnormalities and immune escape by
malignant cells. Semin Cancer Biol. 12:3–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruiz-Cabello F, Cabrera T, Lopez-Nevot MA
and Garrido F: Impaired surface antigen presentation in tumors:
implications for T cell-based immunotherapy. Semin Cancer Biol.
12:15–24. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wolfel T, Klehmann E, Muller C, Schutt KH,
Meyer zum Buschenfelde KH and Knuth A: Lysis of human melanoma
cells by autologous cytolytic T cell clones. Identification of
human histocompatibility leukocyte antigen A2 as a restriction
element for three different antigens. J Exp Med. 170:797–810. 1989.
View Article : Google Scholar
|
|
12
|
Crowley NJ, Darrow TL, Quinn-Allen MA and
Seigler HF: MHC-restricted recognition of autologous melanoma by
tumor-specific cytotoxic T cells. Evidence for restriction by a
dominant HLA-A allele. J Immunol. 146:1692–1699. 1991.PubMed/NCBI
|
|
13
|
Marincola FM, Jaffee EM, Hicklin DJ and
Ferrone S: Escape of human solid tumors from T-cell recognition:
molecular mechanisms and functional significance. Adv Immunol.
74:181–273. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rockett JC, Darnton SJ, Crocker J,
Matthews HR and Morris AG: Expression of HLA-ABC, HLA-DR and
intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin
Pathol. 48:539–544. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rockett JC, Darnton SJ, Crocker J,
Matthews HR and Morris AG: Lymphocyte infiltration in oesophageal
carcinoma: lack of correlation with MHC antigens, ICAM-1, and
tumour stage and grade. J Clin Pathol. 49:264–267. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hosch SB, Izbicki JR, Pichlmeier U,
Stoecklein N, Niendorf A, Knoefel WT, Broelsch CE and Pantel K:
Expression and prognostic significance of immunoregulatory
molecules in esophageal cancer. Int J Cancer. 74:582–587. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vitale M, Rezzani R, Rodella L, Zauli G,
Grigolato P, Cadei M, Hicklin DJ and Ferrone S: HLA class I antigen
and transporter associated with antigen processing (TAP1 and TAP2)
down-regulation in high-grade primary breast carcinoma lesions.
Cancer Res. 58:737–742. 1998.PubMed/NCBI
|
|
18
|
Kageshita T, Hirai S, Ono T, Hicklin DJ
and Ferrone S: Down-regulation of HLA class I antigen-processing
molecules in malignant melanoma: association with disease
progression. Am J Pathol. 154:745–754. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nie Y, Yang G, Song Y, Zhao X, So C, Liao
J, Wang LD and Yang CS: DNA hypermethylation is a mechanism for
loss of expression of the HLA class I genes in human esophageal
squamous cell carcinomas. Carcinogenesis. 22:1615–1623. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seliger B, Atkins D, Bock M, Ritz U,
Ferrone S, Huber C and Storkel S: Characterization of human
lymphocyte antigen class I antigen-processing machinery defects in
renal cell carcinoma lesions with special emphasis on
transporter-associated with antigen-processing down-regulation.
Clin Cancer Res. 9:1721–1727. 2003.
|
|
21
|
Atkins D, Ferrone S, Schmahl GE, Storkel S
and Seliger B: Down-regulation of HLA class I antigen processing
molecules: an immune escape mechanism of renal cell carcinoma? J
Urol. 171:885–889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meissner M, Reichert TE, Kunkel M, Gooding
W, Whiteside TL, Ferrone S and Seliger B: Defects in the human
leukocyte antigen class I antigen processing machinery in head and
neck squamous cell carcinoma: association with clinical outcome.
Clin Cancer Res. 11:2552–2560. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramnath N, Tan D, Li Q, Hylander BL,
Bogner P, Ryes L and Ferrone S: Is downregulation of MHC class I
antigen expression in human non-small cell lung cancer associated
with prolonged survival? Cancer Immunol Immunother. 55:891–899.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ogino T, Shigyo H, Ishii H, Katayama A,
Miyokawa N, Harabuchi Y and Ferrone S: HLA class I antigen
down-regulation in primary laryngeal squamous cell carcinoma
lesions as a poor prognostic marker. Cancer Res. 66:9281–9289.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mehta AM, Jordanova ES, Kenter GG, Ferrone
S and Fleuren GJ: Association of antigen processing machinery and
HLA class I defects with clinicopathological outcome in cervical
carcinoma. Cancer Immunol Immunother. 57:197–206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mizukami Y, Kono K, Maruyama T, Watanabe
M, Kawaguchi Y, Kamimura K and Fujii H: Downregulation of HLA Class
I molecules in the tumour is associated with a poor prognosis in
patients with oesophageal squamous cell carcinoma. Br J Cancer.
99:1462–1467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han LY, Fletcher MS, Urbauer DL, Mueller
P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers
MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S and Sood
AK: HLA class I antigen processing machinery component expression
and intratumoral T-Cell infiltrate as independent prognostic
markers in ovarian carcinoma. Clin Cancer Res. 14:3372–3379. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Hao C, Su P and Shi J:
Down-regulation of HLA class I antigen-processing machinery
components in esophageal squamous cell carcinomas: association with
disease progression. Scand J Gastroenterol. 44:960–969. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogino T, Wang X, Kato S, Miyokawa N,
Harabuchi Y and Ferrone S: Endoplasmic reticulum chaperone-specific
monoclonal antibodies for flow cytometry and immunohistochemical
staining. Tissue Antigens. 62:385–393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bandoh N, Ogino T, Cho HS, Hur SY, Shen J,
Wang X, Kato S, Miyokawa N, Harabuchi Y and Ferrone S: Development
and characterization of human constitutive proteasome and
immunoproteasome subunit-specific monoclonal antibodies. Tissue
Antigens. 66:185–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sobin LH and Wittekind C: TNM
Classification of Malignant Tumours. 6th edit. John Wiley and Sons;
New York: pp. 60–64. 2002
|
|
32
|
Ishikawa K, Miyamoto M, Yoshioka T, Kato
T, Kaji M, Ohbuchi T, Hirano S, Itoh T, Dosaka-Akita H and Kondo S:
Up-regulation of CD40 with juxtacrine activity in human nonsmall
lung cancer cells correlates with poor prognosis. Cancer.
113:530–541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leffers N, Gooden MJ, Mokhova AA, Kast WM,
Boezen HM, Ten Hoor KA, Hollema H, Daemen T, van der Zee AG and
Nijman HW: Down-regulation of proteasomal subunit MB1 is an
independent predictor of improved survival in ovarian cancer.
Gynecol Oncol. 113:256–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
